These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 9600110)
1. Establishment of a novel human B-cell line (OZ) with t(14;18)(q32;q21) and aberrant p53 expression was associated with the homozygous deletions of p15INK4B and p16INK4A genes. Nagai M; Fujita M; Ohmori M; Matsubara S; Taniwaki M; Horiike S; Tasaka T; Koeffler HP; Takahara J Hematol Oncol; 1997 Aug; 15(3):109-19. PubMed ID: 9600110 [TBL] [Abstract][Full Text] [Related]
2. Frequent deletion of p16INK4a/MTS1 and p15INK4b/MTS2 in pediatric acute lymphoblastic leukemia. Okuda T; Shurtleff SA; Valentine MB; Raimondi SC; Head DR; Behm F; Curcio-Brint AM; Liu Q; Pui CH; Sherr CJ Blood; 1995 May; 85(9):2321-30. PubMed ID: 7727766 [TBL] [Abstract][Full Text] [Related]
3. Deletions and loss of expression of p16INK4a and p21Waf1 genes are associated with aggressive variants of mantle cell lymphomas. Pinyol M; Hernandez L; Cazorla M; Balbín M; Jares P; Fernandez PL; Montserrat E; Cardesa A; Lopez-Otín C; Campo E Blood; 1997 Jan; 89(1):272-80. PubMed ID: 8978301 [TBL] [Abstract][Full Text] [Related]
4. Aberrant methylation of p16INK4a and deletion of p15INK4b are frequent events in human esophageal cancer in Linxian, China. Xing EP; Nie Y; Wang LD; Yang GY; Yang CS Carcinogenesis; 1999 Jan; 20(1):77-84. PubMed ID: 9934853 [TBL] [Abstract][Full Text] [Related]
5. Different patterns of homozygous p16INK4A and p15INK4B deletions in childhood acute lymphoblastic leukemias containing distinct E2A translocations. Maloney KW; McGavran L; Odom LF; Hunger SP Leukemia; 1998 Sep; 12(9):1417-21. PubMed ID: 9737691 [TBL] [Abstract][Full Text] [Related]
6. Homozygous deletions at chromosome 9p21 involving p16 and p15 are associated with histologic progression in follicle center lymphoma. Elenitoba-Johnson KS; Gascoyne RD; Lim MS; Chhanabai M; Jaffe ES; Raffeld M Blood; 1998 Jun; 91(12):4677-85. PubMed ID: 9616165 [TBL] [Abstract][Full Text] [Related]
9. The prognostic significance of p16INK4a/p14ARF and p15INK4b deletions in adult acute lymphoblastic leukemia. Faderl S; Kantarjian HM; Manshouri T; Chan CY; Pierce S; Hays KJ; Cortes J; Thomas D; Estrov Z; Albitar M Clin Cancer Res; 1999 Jul; 5(7):1855-61. PubMed ID: 10430092 [TBL] [Abstract][Full Text] [Related]
10. Potential role for concurrent abnormalities of the cyclin D1, p16CDKN2 and p15CDKN2B genes in certain B cell non-Hodgkin's lymphomas. Functional studies in a cell line (Granta 519). Jadayel DM; Lukas J; Nacheva E; Bartkova J; Stranks G; De Schouwer PJ; Lens D; Bartek J; Dyer MJ; Kruger AR; Catovsky D Leukemia; 1997 Jan; 11(1):64-72. PubMed ID: 9001420 [TBL] [Abstract][Full Text] [Related]
11. Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells. Drexler HG Leukemia; 1998 Jun; 12(6):845-59. PubMed ID: 9639410 [TBL] [Abstract][Full Text] [Related]
12. Cumulation of TP53 mutations and p16INK4A/p15INK4B homozygous deletions in human papilloma virus type 16 positive scrotal cancer. Güran S; Pak I Cancer Genet Cytogenet; 1999 Mar; 109(2):108-13. PubMed ID: 10087941 [TBL] [Abstract][Full Text] [Related]
13. MBR rearrangement and P-glycoprotein expression are not independent prognostic factors like p53 protein in malignant lymphoma. Sun RX; Coste J; Segara C; Rousset T; Fabbro M; Rème T; Legouffe E; Klein B; Rossi JF Clin Lab Haematol; 1998 Apr; 20(2):87-94. PubMed ID: 9681218 [TBL] [Abstract][Full Text] [Related]
14. Homozygous codeletion and differential decreased expression of p15INK4b, p16INK4a-alpha and p16INK4a-beta in mouse lung tumor cells. Herzog CR; Soloff EV; McDoniels AL; Tyson FL; Malkinson AM; Haugen-Strano A; Wiseman RW; Anderson MW; You M Oncogene; 1996 Nov; 13(9):1885-91. PubMed ID: 8934534 [TBL] [Abstract][Full Text] [Related]
15. Loss of cyclin-dependent kinase inhibitor genes and chromosome 9 karyotypic abnormalities in human bladder cancer cell lines. Southgate J; Proffitt J; Roberts P; Smith B; Selby P Br J Cancer; 1995 Nov; 72(5):1214-8. PubMed ID: 7577470 [TBL] [Abstract][Full Text] [Related]
16. Inactivations of p16INK4a-alpha, p16INK4a-beta and p15INK4b genes in 2',3'-dideoxycytidine- and 1,3-butadiene-induced murine lymphomas. Zhuang SM; Schippert A; Haugen-Strano A; Wiseman RW; Söderkvist P Oncogene; 1998 Feb; 16(6):803-8. PubMed ID: 9488045 [TBL] [Abstract][Full Text] [Related]
17. Deletion of cyclin-dependent kinase 4 inhibitor genes P15 and P16 in non-Hodgkin's lymphoma. Koduru PR; Zariwala M; Soni M; Gong JZ; Xiong Y; Broome JD Blood; 1995 Oct; 86(8):2900-5. PubMed ID: 7579381 [TBL] [Abstract][Full Text] [Related]
18. P53, p15INK4B, p16INK4A and p57KIP2 mutations during the progression of chronic myeloid leukemia. Güran S; Bahçe M; Beyan C; Korkmaz K; Yalçin A Haematologia (Budap); 1998; 29(3):181-93. PubMed ID: 10069444 [TBL] [Abstract][Full Text] [Related]
19. Deletions of the cyclin-dependent kinase inhibitor genes p16INK4A and p15INK4B in non-Hodgkin's lymphomas. Gombart AF; Morosetti R; Miller CW; Said JW; Koeffler HP Blood; 1995 Aug; 86(4):1534-9. PubMed ID: 7632961 [TBL] [Abstract][Full Text] [Related]
20. Mechanisms of inactivation of p14ARF, p15INK4b, and p16INK4a genes in human esophageal squamous cell carcinoma. Xing EP; Nie Y; Song Y; Yang GY; Cai YC; Wang LD; Yang CS Clin Cancer Res; 1999 Oct; 5(10):2704-13. PubMed ID: 10537333 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]